| Dr Leslie A Scott, MD | |
|
12277 De Paul Dr Ste 305, Bridgeton, MO 63044-2529 | |
| (314) 344-7585 | |
| Not Available |
| Full Name | Dr Leslie A Scott |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 20 Years |
| Location | 12277 De Paul Dr Ste 305, Bridgeton, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295936011 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 2004016262 (Missouri) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 2008018558 (Missouri) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ssm Health Care St Louis | 7810800737 | 138 |
News Archive
While stroke occurrences have been on a consistent decline in the United States since the early 1900s, more women are still dying from them than are men. To aid in curbing these deaths, first-of-their-kind stroke-prevention guidelines for women have been released with the help of one University of Alabama at Birmingham expert.
Researchers in the United Kingdom and Denmark have studied the "see-through" larvae of zebrafish to reveal how wound healing leads to skin cancer. Live imaging shows neutrophils, the protective inflammatory cells of the body's immune system, diverted from an induced wound to any nearby precancerous skin cells.
AstraZeneca's new oral syk inhibitor, fostamatinib (R788), recently in-licensed from Rigel Pharmaceuticals, Inc., significantly improved outcomes of patients with rheumatoid arthritis who responded inadequately to ongoing treatment with methotrexate, according to phase II study data published in The New England Journal of Medicine today.
Building on a plan announced in September of 2007, UC San Diego Health Sciences and the Department of Radiation Oncology are pleased to announce an agreement with Proton Health Partners, LLC (PHP) to plan, develop, and operate The UC San Diego Proton Therapy and Research Center.
› Verified 7 days ago
| Entity Name | Ssm Health Care St Louis |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275586174 PECOS PAC ID: 7810800737 Enrollment ID: O20031118000393 |
News Archive
While stroke occurrences have been on a consistent decline in the United States since the early 1900s, more women are still dying from them than are men. To aid in curbing these deaths, first-of-their-kind stroke-prevention guidelines for women have been released with the help of one University of Alabama at Birmingham expert.
Researchers in the United Kingdom and Denmark have studied the "see-through" larvae of zebrafish to reveal how wound healing leads to skin cancer. Live imaging shows neutrophils, the protective inflammatory cells of the body's immune system, diverted from an induced wound to any nearby precancerous skin cells.
AstraZeneca's new oral syk inhibitor, fostamatinib (R788), recently in-licensed from Rigel Pharmaceuticals, Inc., significantly improved outcomes of patients with rheumatoid arthritis who responded inadequately to ongoing treatment with methotrexate, according to phase II study data published in The New England Journal of Medicine today.
Building on a plan announced in September of 2007, UC San Diego Health Sciences and the Department of Radiation Oncology are pleased to announce an agreement with Proton Health Partners, LLC (PHP) to plan, develop, and operate The UC San Diego Proton Therapy and Research Center.
› Verified 7 days ago
| Entity Name | Ssm Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700966207 PECOS PAC ID: 6608776299 Enrollment ID: O20040729001034 |
News Archive
While stroke occurrences have been on a consistent decline in the United States since the early 1900s, more women are still dying from them than are men. To aid in curbing these deaths, first-of-their-kind stroke-prevention guidelines for women have been released with the help of one University of Alabama at Birmingham expert.
Researchers in the United Kingdom and Denmark have studied the "see-through" larvae of zebrafish to reveal how wound healing leads to skin cancer. Live imaging shows neutrophils, the protective inflammatory cells of the body's immune system, diverted from an induced wound to any nearby precancerous skin cells.
AstraZeneca's new oral syk inhibitor, fostamatinib (R788), recently in-licensed from Rigel Pharmaceuticals, Inc., significantly improved outcomes of patients with rheumatoid arthritis who responded inadequately to ongoing treatment with methotrexate, according to phase II study data published in The New England Journal of Medicine today.
Building on a plan announced in September of 2007, UC San Diego Health Sciences and the Department of Radiation Oncology are pleased to announce an agreement with Proton Health Partners, LLC (PHP) to plan, develop, and operate The UC San Diego Proton Therapy and Research Center.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Leslie A Scott, MD Po Box 955534, Saint Louis, MO 63195-5534 Ph: () - | Dr Leslie A Scott, MD 12277 De Paul Dr Ste 305, Bridgeton, MO 63044-2529 Ph: (314) 344-7585 |
News Archive
While stroke occurrences have been on a consistent decline in the United States since the early 1900s, more women are still dying from them than are men. To aid in curbing these deaths, first-of-their-kind stroke-prevention guidelines for women have been released with the help of one University of Alabama at Birmingham expert.
Researchers in the United Kingdom and Denmark have studied the "see-through" larvae of zebrafish to reveal how wound healing leads to skin cancer. Live imaging shows neutrophils, the protective inflammatory cells of the body's immune system, diverted from an induced wound to any nearby precancerous skin cells.
AstraZeneca's new oral syk inhibitor, fostamatinib (R788), recently in-licensed from Rigel Pharmaceuticals, Inc., significantly improved outcomes of patients with rheumatoid arthritis who responded inadequately to ongoing treatment with methotrexate, according to phase II study data published in The New England Journal of Medicine today.
Building on a plan announced in September of 2007, UC San Diego Health Sciences and the Department of Radiation Oncology are pleased to announce an agreement with Proton Health Partners, LLC (PHP) to plan, develop, and operate The UC San Diego Proton Therapy and Research Center.
› Verified 7 days ago
Sarah Kennedy, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3466 Mckelvey Rd, Bridgeton, MO 63044 Phone: 314-344-8100 | |
Yoram Hahn, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 12255 De Paul Dr, Ste 320, Bridgeton, MO 63044 Phone: 314-344-8100 Fax: 314-344-8102 | |
Donna Ann Robey, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 12255 De Paul Dr, Bridgeton, MO 63044 Phone: 314-344-8100 Fax: 314-344-8102 | |
Stephanie Lee Cogan-levy, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 12277 De Paul Dr, Ste 501s, Bridgeton, MO 63044 Phone: 314-739-8844 Fax: 314-739-5431 | |
Dr. Rochelle Gene Catus, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 12255 De Paul Dr, Ste 765, Bridgeton, MO 63044 Phone: 314-298-8646 Fax: 314-291-8646 | |
Dr. Hamnah Tabassum Siddiqui, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 12277 De Paul Dr Ste 305, Bridgeton, MO 63044 Phone: 314-344-7585 |